Venetoclax-based therapies in pediatric advanced MDS and relapsed/refractory AML: a multicenter retrospective analysis

Affiliations

• ¹ Pediatric Oncology and Hematology "Lalla Seràgnoli," Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
• ² Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy.
• ³ Pediatric Department, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
• ⁴ Pediatrics Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
• ⁵ Department of Pediatric Hematology and Oncology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
• ⁶ Pediatric Hematology, Oncology and Stem Cell Transplant Center, Department of Woman's and Child's Health, University of Padua, Padua, Italy.
• ⁷ Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
• ⁸ Catholic University of the Sacred Heart, Rome, Italy.